Concepedia

Peter Van Vlasselaer

PV

Statistics

Publications

24

Citations

2.8K

H-Index

18

Active since

1984

Affiliations

Coherus BioSciences (United States)(Current)

Flemish Institute for Technological Research

The University of Texas MD Anderson Cancer Center

South Texas Accelerated Research Therapeutics

Sarah Cannon

Peter Van Vlasselaer is an author at Coherus BioSciences (United States) specializing in immunology, life sciences, and cell biology.

Publications per year

1984–2019

24

Publications

24

Allosteric inhibition of lysyl oxidase–like-2 impedes the development of a pathologic microenvironment

Vivian Barry-Hamilton, Rhyannon Spangler, Derek Marshall et al. · Nature Medicine · 2010 · 855 citations

, , +13

Anti-CD40 monoclonal antibodies or CD4+ T cell clones and IL-4 induce IgG4 and IgE switching in purified human B cells via different signaling pathways

Hugues Gascan, J F Gauchat, Gregorio Aversa et al. · The Journal of Immunology · 1991 · 269 citations · Full text

, , +14

PEGylated IL-10 (Pegilodecakin) Induces Systemic Immune Activation, CD8+ T Cell Invigoration and Polyclonal T Cell Expansion in Cancer Patients

Aung Naing, Jeffrey R. Infante, Kyriakos P. Papadopoulos et al. · Cancer Cell · 2018 · 251 citations · Full text

, , +17

Transforming growth factor-beta directs IgA switching in human B cells

Peter Van Vlasselaer, Juha Punnonen, J E de Vries · The Journal of Immunology · 1992 · 231 citations

, , +17

Safety, Antitumor Activity, and Immune Activation of Pegylated Recombinant Human Interleukin-10 (AM0010) in Patients With Advanced Solid Tumors

Aung Naing, Kyriakos P. Papadopoulos, Karen A. Autio et al. · Journal of Clinical Oncology · 2016 · 217 citations

, , +17

1–5 of 24